Stephen J.LurieMD, PhDIndividualAuthor
To the Editor: Dr Attaran and Mr Gillespie-White1 attempt to show that patents are not a substantial
barrier to antiretroviral treatment access in Africa today. But our experience
with Médecins Sans Frontières (Doctors Without Borders) in Africa
shows that such an analysis is meaningless if the drug combinations required
for effective therapy in a particular context are not considered.
Goemaere E, Kaninda A, Ciaffi L, et al. Do Patents Prevent Access to Drugs for HIV in Developing Countries? JAMA. 2002;287(7):840–843. doi:10.1001/jama.287.7.839
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: